Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 1, 2017

View Archived Issues

Fujifilm to begin clinical testing of FF-10832 for advanced solid tumors next year

FDA issues refusal to file letter for SteadyMed's Trevyent NDA

Akcea announces NDA submission for volanesorsen in familial chylomicronemia syndrome

Bayer submits BLA to FDA for BAY-94-9027

Sunovion files NDA for dasotraline to treat ADHD

Daiichi Sankyo terminates agreement with Charleston Laboratories

Topline results from Asian REDUCER trial of mirogabalin in diabetic peripheral neuropathic pain

Sumitomo Dainippon Pharma submits an application in Japan for an additional indication for Trerief

Bristol-Myers Squibb explores adaptor-associated kinase 1 as a target for neuropathic pain

Thermo Fisher forms European Immuno-Oncology Consortium

Serum APEX found a marker of myocarditis severity

European Commission approves pediatric formulation of Mimpara

Mochida compound shows effective targeting of FFAR1 for diabetes

Horizon Discovery completes acquisition of GE Healthcare Dharmacon

Aptevo and MorphoSys end partnership for MOR-209

FDA awards fast track designation to Iovance's LN-144 for advanced melanoma

Taisho Pharmaceutical presents 20-HETE synthase inhibitors

Heptares begins leukotriene receptor modulator collaboration with Juntendo University

ImMAGE Biotherapeutics terminates operations

Roche and Genentech patent new Janus kinase inhibitors

Sprint Bioscience AB divulges PIK3C3 inhibitors

RegeneRx completes license expansion agreement with GtreeBNT for RGN-137

Oragenics initiates phase II trial of AG-013 for oral mucositis

Janssen Vaccines & Prevention BV patent adenoviral vectors for treating malaria

Penn State Research Foundation divulges CCK2 receptor-targeting DNA aptamers

Novel compounds target MYC via G-quadruplex in the promoter region

Janssen Biotech terminates duvortuxizumab agreement with MacroGenics

Novel susceptibility loci identified for aortic aneurysm in Japanese individuals

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.